Steward Partners Investment Advisory’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$733 Hold
405
﹤0.01% 4232
2025
Q4
$547 Hold
405
﹤0.01% 4145
2025
Q3
$660 Hold
405
﹤0.01% 4093
2025
Q2
$393 Hold
405
﹤0.01% 3981
2025
Q1
$286 Hold
405
﹤0.01% 3898
2024
Q4
$326 Hold
405
﹤0.01% 3883
2024
Q3
$402 Hold
405
﹤0.01% 3620
2024
Q2
$628 Hold
405
﹤0.01% 3450
2024
Q1
$664 Hold
405
﹤0.01% 3406
2023
Q4
$233 Hold
405
﹤0.01% 3404
2023
Q3
$162 Hold
405
﹤0.01% 3306
2023
Q2
$220 Hold
405
﹤0.01% 3231
2023
Q1
$346 Hold
405
﹤0.01% 3196
2022
Q4
$527 Hold
405
﹤0.01% 3188
2022
Q3
$1K Hold
405
﹤0.01% 3147
2022
Q2
$1K Hold
405
﹤0.01% 3142
2022
Q1
$1K Buy
+405
New +$1.42K ﹤0.01% 3203
2021
Q4
Sell
-15
Closed 3276
2021
Q3
$0 Hold
15
﹤0.01% 3275
2021
Q2
$0 Sell
15
-610
-98% -$5.15K ﹤0.01% 7308
2021
Q1
$4.24K Buy
+625
New +$4.16K ﹤0.01% 3049

Other funds holding OCGN

Steward Partners Investment Advisory's OCGN Position: Q1 2026 in Review

Steward Partners Investment Advisory held its Ocugen (OCGN) position steady in Q1 2026 at 405 shares worth $733. The position accounts for ﹤0.01% of the portfolio, ranked #4232.

Steward Partners Investment Advisory first reported a position in OCGN in Q1 2021 and has held it in 20 quarters since. The position peaked at $4.24K in Q1 2021. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

  • Steward Partners Investment Advisory held 405 shares of Ocugen worth $733 as of Q1 2026.
  • Steward Partners Investment Advisory left its Ocugen share count unchanged in Q1 2026.
  • Ocugen made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #4232 holding.
  • Steward Partners Investment Advisory first reported a position in Ocugen in Q1 2021 and has held it in 20 quarters since.
  • Steward Partners Investment Advisory's Ocugen position peaked at $4.24K in Q1 2021.
  • 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.